Dow turns lower heading toward closing bell, while S&P 500, Nasdaq rise in choppy stock-market trade

US stock benchmarks were mixed heading toward the closing bell Tuesday, after three days of heavy losses, with the Dow Jones Industrial Average turning lower on the eve of a key inflation reading. How are stock indexes performing? The Dow Jones Industrial Average DJIA fell almost 144 points, or 0.5%, to about 32,101.91 The blue-chip … Read more

Here’s a list of 50 companies that are well-armed to beat back inflation

Another turnaround Tuesday may be in the cards after a litany of concerns including stagflation dragged the S&P 500 SPX below 4,000 for the first time since 2021. As investors try to regroup from the worst three-day stock stretch in two yearsone more hard day of selling for the S&P might be a good thing, … Read more

FAANG stocks plus Microsoft lost $ 1.4 trillion in market value during April

On another difficult Friday afternoon for the stock market, the broad US indexes ended with significant declines. One element that stood out during such a rough year for technology stocks was that the FAANG group (Facebook holding company Meta Platforms Inc. FB, Apple Inc. AAPL, Inc. AMZN, Netflix Inc. NFLX, Google holding company Alphabet … Read more

The FDA restricts Johnson & Johnson’s COVID-19 vaccine because of the risk of blood clots

WASHINGTON – U.S. regulators on Thursday strictly limited who can accept Johnson & Johnson’s COVID -19 vaccine because the risk of blood clots is rare but serious. The Food and Drug Administration states that the injection should only be given to adults who cannot receive a different vaccine or specifically request J & J’s JNJ, … Read more

Pfizer’s got its eye on more than the COVID-19 market

Pfizer PFE, + 0.75% is already laying the groundwork for what the pharmaceutical behemoth will look like when revenue from its outsized COVID-19 vaccine and treatment franchise begins to wane. The company on Tuesday reiterated its expectation that Comirnaty, the COVID-19 vaccine it developed with BioNTech BNTX, + 1.75%, is set to bring in $ … Read more